Diabetic nephropathy is the leading cause of kidney disease in patients starting renal
replacement therapy and affects∼ 40% of type 1 and type 2 diabetic patients. It increases …

Historically, nutrition principles and recommendations for diabetes and related
complications have been based on scientific evidence and diabetes knowledge when …

In the not-so-distant past, type 2 diabetes mellitus was thought to be a relatively benign
condition, at least in the elderly, with relatively little effect on life expectancy or renal function …

The Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study
of Diabetes (EASD) has issued a series of updated statements regarding the nutritional …

Background—A high serum total homocysteine (tHcy) concentration is a risk factor for death,
but the strength of the relation in patients with type 2 (non–insulin-dependent) diabetes …

Renal disease and hypertension in non–insulin-dependent diabetes mellitus. Recent
epidemiologic data demonstrate a dramatic increase in the incidence of end-stage renal …

High-protein (HP) weight-loss diets have existed in the United States for decades, although
their popularity has recently surged as obesity has become more common. Despite their …

Serum homocysteine level and protein intake are related to risk of microalbuminuria: The
Hoorn Study. Background Microalbuminuria (MA) is a strong predictor of cardiovascular …

End‐stage renal failure (ESRF) in diabetic patients, mostly type 2, has become the most
frequent cause of renal replacement therapy in western Europe. The majority of patients with …

It is an irony of medical progress that the renal involvement in diabetes mellitus type 2 had
been considered twenty years ago (1) as a benign condition for the kidney without causing …